Atlas Trials

Investigating the Gut Microbiota Modulation Effects of Allicin for Cardiovascular Disease Protection and Establishing Microbiota Directed Personalized Nutrition Guidance With Novel Humanized Gnotobiotic Mice Model, Microbial Culturomics and Metabolomic Technique

Clinical trial NCT04545879 · COMPLETED

Trial details

NCT number
NCT04545879
Sponsor
National Taiwan University Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Atherosclerosis
Start date
2019-03-18
Primary completion
2019-05-18
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.